• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Ursodeoxycholic Acid

Ursodeoxycholic Acid

Product ID U6873
Cas No. 128-13-2
Purity ≥98%
Product Unit SizeCostQuantityStock
1 g $60.10 In stock
5 g $180.30 In stock
25 g $375.60 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Ursodeoxycholic acid is an endogenous secondary bile acid produced by bacterial metabolism of bile acids in the intestines. Ursodeoxycholic acid decreases cholesterol absorption, dissolves gallstones, and treats cirrhosis and other liver diseases. This compound exhibits immunosuppressive, antioxidative, hepatoprotective, anticancer, and gastrointestinal motility modulating activities. In animal models, ursodeoxycholic acid decreases spleenocyte proliferation and levels of IL-2, L-6, and IFN-γ, increases levels of IL-10, and prevents allograft rejection. In other animal models, this compound increases levels of glutathione and decreases levels of malondialdehyde, myeloperoxidase, and ROS. In colon cancer cells, ursodeoxycholic acid inhibits cellular proliferation and induces apoptosis; similarly, it also induces differentiation, senescence, and HDAC6-dependent hypoacetylation. In other cancer models, this compound inhibits telomerase and may exhibit chemopreventive potential. In vivo, ursodeoxycholic acid decreases gastrointestinal transit time and increases gastric emptying rates.

Product Info

Cas No.

128-13-2

Purity

≥98%

Formula

C24H40O4

Formula Wt.

392.57

Chemical Name

(3α,5β,7β)-3,7-Dihydroxycholan-24-oic acid

IUPAC Name

(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2, 3,4,5,6,7,8,9,11,12,14,15,16, 17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

Synonym

Ursodiol, Actigall, Delursan, Desol, Litursol, Peptarom, Urdes, Ursofalk, Ursolvan

Melting Point

203°C

Solubility

Insoluble in water. Soluble in ethanol. Slightly soluble in chloroform. Soluble in DMSO (>100 mg/mL).

Appearance

White Fine Crystalline Powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

U6873 MSDS PDF

Info Sheet

U6873 Info Sheet PDF

References

Zhang Q, Nakaki T, Iwami D, et al. Induction of regulatory T cells and indefinite survival of fully allogeneic cardiac grafts by ursodeoxycholic acid in mice. Transplantation. 2009 Dec 27;88(12):1360-70. PMID: 20029332.

El-Sherbiny GA, Taye A, Abdel-Raheem IT. Role of ursodeoxycholic acid in prevention of hepatotoxicity caused by amoxicillin-clavulanic acid in rats. Ann Hepatol. 2009 Apr-Jun;8(2):134-40. PMID: 19502657.

Akare S, Jean-Louis S, Chen W, et al. Ursodeoxycholic acid modulates histone acetylation and induces differentiation and senescence. Int J Cancer. 2006 Dec 15;119(12):2958-69. PMID: 17019713.

Colecchia A, Mazzella G, Sandri L, et al. Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients. World J Gastroenterol. 2006 Sep 7;12(33):5336-43. PMID: 16981264.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • W4096

    WKYMVM-NH2

    Synthetic peptide; FPRL1 agonist.

    ≥95%
  • N1977

    Neurokinin A (4-10)

    Endogenous neuropeptide, also known as substanc...

    ≥95%
  • A5072

    Amsacrine

    Acridine derivative, DNA intercalator; topoisom...

    ≥98%
  • A5133

    Amiloride Hydrochloride Dihydrate

    K+-sparing diuretic; ENaC and acid-sensing ion ...

    ≥98%
  • P200600

    PF-06873600

    CDK2/4/6 inhibitor

    ≥98%
  • B022691

    Baricitinib

    Selective and reversible JAK inhibitor.

    ≥99%
  • A1592

    ADX-47273

    mGluR5 positive modulator.

    ≥98%
  • I058584

    Ibotenic Acid

    Analog of glutamate

    ≥98%
  • C4517

    Clenbuterol Hydrochloride

    β2-adrenergic agonist.

    ≥98%
  • A044176

    Abemaciclib

    CDK inhibitor.

    ≥98%
  • T7133

    Trimetazidine Dihydrochloride

    Long-chain 3-ketoacyl-CoA thiolase inhibitor, p...

    ≥99%
  • D023721

    Dasatinib

    Multikinase inhibitor.

    ≥99%
  • D5690

    Doxazosin Mesylate

    Quinazoline; α1-adrenergic antagonist.

    ≥98%
  • K0276

    Katacalcin

    Peptide found in crustaceans; PKA activator.

    ≥95%
  • A4544

    Allyl Disulfide

    Organosulfur found in garlic.

    ≥98%
  • F334451

    Filipin Complex

    A probe for cholesterol in biological membranes...

    ≥97%
  • G4798

    Glycitein

    Aglycone isoflavone found in soy and red clover...

    ≥98%
  • P1952

    Penitrem A

    Neuroactive mycotoxin produced by Penicillum an...

    ≥97%
  • P1202

    PD-325901

    MEK1/2 and Raf inhibitor.

    ≥99%
  • I5315

    Indomethacin

    NSAID; COX-1/2 inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only